These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 39240276)
1. Integrative Bioinformatics Analysis: Unraveling Variant Signatures and Single-Nucleotide Polymorphism Markers Associated with 5-FU-Based Chemotherapy Resistance in Colorectal Cancer Patients. Askari M; Mirzaei E; Navapour L; Karimpour M; Rejali L; Sarirchi S; Nazemalhosseini-Mojarad E; Nobili S; Cava C; Sadeghi A; Fatemi N J Gastrointest Cancer; 2024 Dec; 55(4):1607-1619. PubMed ID: 39240276 [TBL] [Abstract][Full Text] [Related]
2. Potentially functional SNPs (pfSNPs) as novel genomic predictors of 5-FU response in metastatic colorectal cancer patients. Wang J; Wang X; Zhao M; Choo SP; Ong SJ; Ong SY; Chong SS; Teo YY; Lee CG PLoS One; 2014; 9(11):e111694. PubMed ID: 25372392 [TBL] [Abstract][Full Text] [Related]
3. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer. Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X Front Immunol; 2022; 13():887048. PubMed ID: 35784334 [TBL] [Abstract][Full Text] [Related]
4. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway. Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215 [TBL] [Abstract][Full Text] [Related]
5. Integrated analysis reveals a novel 5-fluorouracil resistance-based prognostic signature with promising implications for predicting the efficacy of chemotherapy and immunotherapy in patients with colorectal cancer. Hou Y; Zhang F; Zong J; Li T; Gan W; Lv S; Yan Z; Zeng Z; Yang L; Zhou M; Zhao W; Yang M Apoptosis; 2024 Aug; 29(7-8):1126-1144. PubMed ID: 38824480 [TBL] [Abstract][Full Text] [Related]
6. The relationship between 5-fluorouracil sensitivity and single nucleotide polymorphisms of the orotate phosphoribosyl transferase gene in colorectal cancer. Kitajima M; Takita N; Hata M; Maeda T; Sakamoto K; Kamano T; Ochiai T Oncol Rep; 2006 Jan; 15(1):161-5. PubMed ID: 16328050 [TBL] [Abstract][Full Text] [Related]
7. Integration of genetic variants and gene network for drug repurposing in colorectal cancer. Irham LM; Wong HS; Chou WH; Adikusuma W; Mugiyanto E; Huang WC; Chang WC Pharmacol Res; 2020 Nov; 161():105203. PubMed ID: 32950641 [TBL] [Abstract][Full Text] [Related]
8. SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients. Kap EJ; Seibold P; Scherer D; Habermann N; Balavarca Y; Jansen L; Zucknick M; Becker N; Hoffmeister M; Ulrich A; Benner A; Ulrich CM; Burwinkel B; Brenner H; Chang-Claude J Int J Cancer; 2016 Jun; 138(12):2993-3001. PubMed ID: 26835885 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit. Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060 [TBL] [Abstract][Full Text] [Related]
10. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10. Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis. Chen J; Wang Z; Shen X; Cui X; Guo Y Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508 [TBL] [Abstract][Full Text] [Related]
12. Selumetinib overcomes ITGA2-induced 5-fluorouracil resistance in colorectal cancer. Qin J; Hu S; Lou J; Xu M; Gao R; Xiao Q; Chen Y; Ding M; Pan Y; Wang S Int Immunopharmacol; 2024 Aug; 137():112487. PubMed ID: 38889513 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524 [TBL] [Abstract][Full Text] [Related]
14. Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy. Godai TI; Suda T; Sugano N; Tsuchida K; Shiozawa M; Sekiguchi H; Sekiyama A; Yoshihara M; Matsukuma S; Sakuma Y; Tsuchiya E; Kameda Y; Akaike M; Miyagi Y BMC Cancer; 2009 Dec; 9():420. PubMed ID: 19954513 [TBL] [Abstract][Full Text] [Related]
15. CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer. Delhorme JB; Bersuder E; Terciolo C; Vlami O; Chenard MP; Martin E; Rohr S; Brigand C; Duluc I; Freund JN; Gross I Biomed Pharmacother; 2022 Mar; 147():112630. PubMed ID: 35051860 [TBL] [Abstract][Full Text] [Related]
16. The Effect of miR-200c Inhibition on Chemosensitivity (5- FluoroUracil) in Colorectal Cancer. Heydari K; Saidijam M; Sharifi MR; Dermani FK; Soleimani Asl S; Shabab N; Najafi R Pathol Oncol Res; 2018 Jan; 24(1):145-151. PubMed ID: 28411308 [TBL] [Abstract][Full Text] [Related]
17. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629 [TBL] [Abstract][Full Text] [Related]
18. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells. Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084 [TBL] [Abstract][Full Text] [Related]
19. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer. Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687 [TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients. Pardini B; Rosa F; Naccarati A; Vymetalkova V; Ye Y; Wu X; di Gaetano C; Buchler T; Novotny J; Matullo G; Vodicka P Carcinogenesis; 2015 Jan; 36(1):82-6. PubMed ID: 25368035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]